BR0010815A - Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa - Google Patents
Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosaInfo
- Publication number
- BR0010815A BR0010815A BR0010815-4A BR0010815A BR0010815A BR 0010815 A BR0010815 A BR 0010815A BR 0010815 A BR0010815 A BR 0010815A BR 0010815 A BR0010815 A BR 0010815A
- Authority
- BR
- Brazil
- Prior art keywords
- intravenous administration
- globulin
- immune globulin
- gamma
- preparing viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"MéTODO DE PREPARAçãO DE GLOBULINA IMUNE DUPLAMENTE INATIVADA VIRALMENTE PARA ADMINISTRAçãO INTRAVENOSA". Um processo para produzir uma solução de gama globulina intravenosamente administrável substancialmente livre de contaminação de virose por fracionamento de uma solução de gama globulina e então tratar a gama globulina purificada, em qualquer ordem, com um solvente - detergente para inativação viral e um tratamento por aquecimento para inativação viral. A seguir, as impurezas desnaturadas, solvente residual e agregado gerado pelo tratamento por aquecimento são removidos da gama-globulina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/316,117 US6441144B1 (en) | 1999-05-20 | 1999-05-20 | Method for repairing dual virally inactivated immune globulin for intravenous administration |
PCT/US2000/008222 WO2000071142A1 (en) | 1999-05-20 | 2000-05-17 | Method for preparing dual virally inactivated immune globulin for intravenous administration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010815A true BR0010815A (pt) | 2002-06-11 |
Family
ID=23227544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010815-4A BR0010815A (pt) | 1999-05-20 | 2000-05-17 | Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa |
Country Status (13)
Country | Link |
---|---|
US (2) | US6441144B1 (pt) |
EP (1) | EP1183036A4 (pt) |
JP (1) | JP2003528803A (pt) |
KR (1) | KR20020019916A (pt) |
CN (1) | CN1351500A (pt) |
AU (1) | AU757568B2 (pt) |
BR (1) | BR0010815A (pt) |
CA (1) | CA2371356A1 (pt) |
CZ (1) | CZ20013792A3 (pt) |
IL (1) | IL146039A0 (pt) |
PL (1) | PL361133A1 (pt) |
WO (1) | WO2000071142A1 (pt) |
ZA (1) | ZA200109516B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6995246B1 (en) * | 2000-10-19 | 2006-02-07 | Akzo Nobel N.V. | Methods for removing suspended particles from soluble protein solutions |
ES2184594B1 (es) * | 2001-01-17 | 2004-01-01 | Probitas Pharma Sa | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. |
JP5037331B2 (ja) * | 2004-03-19 | 2012-09-26 | バクスター・インターナショナル・インコーポレイテッド | 出血性障害の処置のための第ixa因子 |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
US20080214795A1 (en) * | 2007-02-14 | 2008-09-04 | Amgen Inc. | Method of isolating antibodies by precipitation |
PE20090100A1 (es) * | 2007-03-30 | 2009-02-26 | Wyeth Corp | Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas |
WO2009046168A1 (en) | 2007-10-02 | 2009-04-09 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
WO2010059232A1 (en) * | 2008-11-20 | 2010-05-27 | Biogen Idec Ma Inc. | Arginine inactivation of viruses |
EP2519537A4 (en) * | 2009-12-29 | 2013-07-10 | Reddys Lab Ltd Dr | CLEANING PROTEINS |
HUE053664T2 (hu) | 2011-07-18 | 2021-07-28 | The United States Of America | Eljárások és készítmények Polyomavírussal összefüggõ betegségek gátlására |
CN103160486A (zh) * | 2013-04-02 | 2013-06-19 | 黑龙江迪龙制药有限公司 | 一种猪凝血酶的制备方法 |
EP3313273A4 (en) * | 2015-06-24 | 2019-03-20 | The Medical College of Wisconsin, Inc. | SYSTEM AND METHOD FOR LOCALIZED PROCESSING OF CARDS OF QUANTITATIVE SUSCEPTIBILITY IN MAGNETIC RESONANCE IMAGING |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801123C2 (de) * | 1977-01-26 | 1986-01-02 | Armour Pharma GmbH & Co KG, 3440 Eschwege | Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates |
US4820805A (en) | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
JPS6042336A (ja) * | 1983-08-18 | 1985-03-06 | Nippon Seiyaku Kk | 免疫グロブリンの製造方法 |
US4835257A (en) | 1984-07-07 | 1989-05-30 | Armour Pharma Gmbh | Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer |
FR2582515B1 (fr) | 1985-05-30 | 1988-11-04 | Merieux Inst | Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues |
JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
US4841023A (en) | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
CA1310267C (en) | 1986-07-09 | 1992-11-17 | Yutaka Hirao | Process for heat treating chemically unmodified _-globulin |
DE3825429C2 (de) | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
JP2926728B2 (ja) * | 1988-12-29 | 1999-07-28 | 吉富製薬株式会社 | 蛋白質含有組成物の製造方法 |
JP2965069B2 (ja) * | 1989-01-13 | 1999-10-18 | 吉富製薬株式会社 | 蛋白質含有組成物の製造方法 |
EP0378208B2 (en) | 1989-01-13 | 2003-01-15 | Mitsubishi Pharma Corporation | Production method for protein-containing composition |
JP3297433B2 (ja) | 1989-06-15 | 2002-07-02 | ローヌ−プーラン ローラー インターナショナル (ホウルディングス) インコーポレイテッド | ウイルスで汚染された薬理組成物中のウイルスの不活性化方法 |
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
JP3145696B2 (ja) | 1990-10-05 | 2001-03-12 | 日本ケミカルリサーチ株式会社 | 分泌型免疫グロブリンa製剤の製造法 |
US5110910A (en) | 1991-03-25 | 1992-05-05 | Miles Inc. | Virucidal euglobulin precipitation |
WO1994017834A1 (de) * | 1993-02-09 | 1994-08-18 | Octapharma Ag | Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind |
WO1998030230A1 (fr) * | 1997-01-09 | 1998-07-16 | Yoshitomi Pharmaceutical Industries, Ltd. | Compositions proteinees et procede de production |
-
1999
- 1999-05-20 US US09/316,117 patent/US6441144B1/en not_active Expired - Fee Related
-
2000
- 2000-05-17 BR BR0010815-4A patent/BR0010815A/pt not_active IP Right Cessation
- 2000-05-17 PL PL36113300A patent/PL361133A1/xx unknown
- 2000-05-17 CA CA002371356A patent/CA2371356A1/en not_active Abandoned
- 2000-05-17 CZ CZ20013792A patent/CZ20013792A3/cs unknown
- 2000-05-17 JP JP2000619445A patent/JP2003528803A/ja active Pending
- 2000-05-17 KR KR1020017014717A patent/KR20020019916A/ko not_active Application Discontinuation
- 2000-05-17 IL IL14603900A patent/IL146039A0/xx unknown
- 2000-05-17 WO PCT/US2000/008222 patent/WO2000071142A1/en not_active Application Discontinuation
- 2000-05-17 CN CN00807723A patent/CN1351500A/zh active Pending
- 2000-05-17 EP EP00928130A patent/EP1183036A4/en not_active Withdrawn
- 2000-05-17 AU AU46410/00A patent/AU757568B2/en not_active Ceased
-
2001
- 2001-05-22 US US09/861,713 patent/US6504012B2/en not_active Expired - Fee Related
- 2001-11-19 ZA ZA200109516A patent/ZA200109516B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20013792A3 (cs) | 2002-04-17 |
CA2371356A1 (en) | 2000-11-30 |
JP2003528803A (ja) | 2003-09-30 |
EP1183036A4 (en) | 2004-12-01 |
EP1183036A1 (en) | 2002-03-06 |
PL361133A1 (en) | 2004-09-20 |
US6441144B1 (en) | 2002-08-27 |
CN1351500A (zh) | 2002-05-29 |
US20010044524A1 (en) | 2001-11-22 |
US6504012B2 (en) | 2003-01-07 |
IL146039A0 (en) | 2002-07-25 |
KR20020019916A (ko) | 2002-03-13 |
AU4641000A (en) | 2000-12-12 |
WO2000071142A1 (en) | 2000-11-30 |
ZA200109516B (en) | 2002-11-06 |
AU757568B2 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010815A (pt) | Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa | |
ES2148332T3 (es) | Procedimiento para la produccion de concentrado de inmunoglobulinas g. | |
EA200401579A1 (ru) | Замещенные соединения метациклина (варианты), фармацевтическая композиция (варианты) и способ лечения чувствительного к тетрациклину состояния млекопитающего (варианты) | |
NZ620988A (en) | Method for purifying recombinant adamts13 and other proteins and compositions thereof | |
PL325338A1 (en) | Methods of and compositions for selectivel;y modifying nucleic acids | |
EA199901031A1 (ru) | Производные бензимидазола | |
BR9201848A (pt) | Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos | |
PT98565A (pt) | Um processo de producao de uma composicao para o tratamento da infeccao por hsv | |
DE60039715D1 (de) | Hcv-impfstoff zusammensetzungen | |
ATE45961T1 (de) | Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. | |
AR018260A1 (es) | Un proceso para preparar una solucion de gammaglobulina que puede ser administrada por via intravenosa, y solucion de gammaglobulina obtenida por dichoproceso | |
DE60222899D1 (de) | Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv) | |
DE602005009634D1 (de) | Niedrigkonzentrations-Lösungsmittel/Detergensprozess von Immunglobulin mit Vorbehandlungsschritt | |
DK0525502T4 (da) | Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger | |
DE68923169D1 (de) | Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen. | |
JPS59134730A (ja) | 血液凝固第8因子の加熱処理法 | |
RU99120190A (ru) | Способ получения раствора гамма-глобулина, предназначенного для внутривенного введения и продукт, получаемый этим способом | |
ES8505820A1 (es) | Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b | |
NO902499L (no) | Fremgangsmaate for fremstilling av rensede albuminopploesninger. | |
EA200100133A1 (ru) | Оксазолидиноны для лечения инфекционных болезней глаз | |
ATE298582T1 (de) | Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen | |
BR0011648A (pt) | Método de fabricação de imunoglobulina intravenosa e produto resultante | |
DK0648243T3 (da) | Fremgangsmåde til reduktion af bløde acrylpolymerers klæbrighed | |
DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner | |
DE69109314D1 (de) | Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |